Zurich: Swiss drug regulator swismedic Said on Monday it approved ronaprev, an antibody treatment jointly developed by Roche and Regeneron, to treat COVID-19 Patient.
“In this process, no data effect “Omicron was presented against the variant,” SwissMedic said in a statement.
Antibody treatments are already available for covid-19. was authorized for prescription in Switzerland under ordinance From 3 Apr 15, SwissMedic said.
“In this process, no data effect “Omicron was presented against the variant,” SwissMedic said in a statement.
Antibody treatments are already available for covid-19. was authorized for prescription in Switzerland under ordinance From 3 Apr 15, SwissMedic said.
,